Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
Sung Soon Park
Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
Davin Lee
Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
Kyung Min Kim
Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea
Yeonjin Jeong
Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
Eun Seon Kim
Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea
Jae Ho Cho
Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
Yu-Mi Jeon
Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea
C-K James Shen
Taipei Medical University/Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan
Hyung-Jun Kim
Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea
Daehee Hwang
School of Biological Sciences, Seoul National University, Seoul, Republic of Korea
Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea; Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea; Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea
Cytoplasmic accumulation of TDP-43 in motor neurons is the most prominent pathological feature in amyotrophic lateral sclerosis (ALS). A feedback cycle between nucleocytoplasmic transport (NCT) defect and TDP-43 aggregation was shown to contribute to accumulation of TDP-43 in the cytoplasm. However, little is known about cellular factors that can control the activity of NCT, thereby affecting TDP-43 accumulation in the cytoplasm. Here, we identified via FRAP and optogenetics cytosolic calcium as a key cellular factor controlling NCT of TDP-43. Dynamic and reversible changes in TDP-43 localization were observed in Drosophila sensory neurons during development. Genetic and immunohistochemical analyses identified the cytosolic calcium-Calpain-A-Importin α3 pathway as a regulatory mechanism underlying NCT of TDP-43. In C9orf72 ALS fly models, upregulation of the pathway activity by increasing cytosolic calcium reduced cytoplasmic accumulation of TDP-43 and mitigated behavioral defects. Together, these results suggest the calcium-Calpain-A-Importin α3 pathway as a potential therapeutic target of ALS.